These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 2037363

  • 1. Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells.
    Mobley HL, Chippendale GR, Swihart KG, Welch RA.
    Infect Immun; 1991 Jun; 59(6):2036-42. PubMed ID: 2037363
    [Abstract] [Full Text] [Related]

  • 2. Internalization of Proteus mirabilis by human renal epithelial cells.
    Chippendale GR, Warren JW, Trifillis AL, Mobley HL.
    Infect Immun; 1994 Aug; 62(8):3115-21. PubMed ID: 8039879
    [Abstract] [Full Text] [Related]

  • 3. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains.
    Mobley HL, Green DM, Trifillis AL, Johnson DE, Chippendale GR, Lockatell CV, Jones BD, Warren JW.
    Infect Immun; 1990 May; 58(5):1281-9. PubMed ID: 2182540
    [Abstract] [Full Text] [Related]

  • 4. Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources.
    Mobley HL, Chippendale GR.
    J Infect Dis; 1990 Mar; 161(3):525-30. PubMed ID: 2179424
    [Abstract] [Full Text] [Related]

  • 5. Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection.
    Mobley HL, Belas R, Lockatell V, Chippendale G, Trifillis AL, Johnson DE, Warren JW.
    Infect Immun; 1996 Dec; 64(12):5332-40. PubMed ID: 8945585
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic activity of the Proteus hemolysin HpmA.
    Swihart KG, Welch RA.
    Infect Immun; 1990 Jun; 58(6):1861-9. PubMed ID: 2341182
    [Abstract] [Full Text] [Related]

  • 7. Molecular detection of HpmA and HlyA hemolysin of uropathogenic Proteus mirabilis.
    Cestari SE, Ludovico MS, Martins FH, da Rocha SP, Elias WP, Pelayo JS.
    Curr Microbiol; 2013 Dec; 67(6):703-7. PubMed ID: 23884594
    [Abstract] [Full Text] [Related]

  • 8. Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection.
    Johnson DE, Russell RG, Lockatell CV, Zulty JC, Warren JW, Mobley HL.
    Infect Immun; 1993 Jul; 61(7):2748-54. PubMed ID: 8514376
    [Abstract] [Full Text] [Related]

  • 9. The HpmA hemolysin is more common than HlyA among Proteus isolates.
    Swihart KG, Welch RA.
    Infect Immun; 1990 Jun; 58(6):1853-60. PubMed ID: 2341181
    [Abstract] [Full Text] [Related]

  • 10. Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection.
    Alamuri P, Eaton KA, Himpsl SD, Smith SN, Mobley HL.
    Infect Immun; 2009 Feb; 77(2):632-41. PubMed ID: 19029299
    [Abstract] [Full Text] [Related]

  • 11. Binding to and killing of human renal epithelial cells by hemolytic P-fimbriated E. coli.
    Trifillis AL, Donnenberg MS, Cui X, Russell RG, Utsalo SJ, Mobley HL, Warren JW.
    Kidney Int; 1994 Oct; 46(4):1083-91. PubMed ID: 7861702
    [Abstract] [Full Text] [Related]

  • 12. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli.
    Koronakis V, Cross M, Senior B, Koronakis E, Hughes C.
    J Bacteriol; 1987 Apr; 169(4):1509-15. PubMed ID: 3549692
    [Abstract] [Full Text] [Related]

  • 13. Use of green fluorescent protein to assess urease gene expression by uropathogenic Proteus mirabilis during experimental ascending urinary tract infection.
    Zhao H, Thompson RB, Lockatell V, Johnson DE, Mobley HL.
    Infect Immun; 1998 Jan; 66(1):330-5. PubMed ID: 9423875
    [Abstract] [Full Text] [Related]

  • 14. Allicin from garlic inhibits the biofilm formation and urease activity of Proteus mirabilis in vitro.
    Ranjbar-Omid M, Arzanlou M, Amani M, Shokri Al-Hashem SK, Amir Mozafari N, Peeri Doghaheh H.
    FEMS Microbiol Lett; 2015 May; 362(9):. PubMed ID: 25837813
    [Abstract] [Full Text] [Related]

  • 15. The effect of acetohydroxamic acid on the induction of bacterial ureases.
    Rosenstein I, Hamilton-Miller JM, Brumfitt W.
    Invest Urol; 1980 Sep; 18(2):112-4. PubMed ID: 6997229
    [Abstract] [Full Text] [Related]

  • 16. Outer membrane protein profiles and multilocus enzyme electrophoresis analysis for differentiation of clinical isolates of Proteus mirabilis and Proteus vulgaris.
    Kappos T, John MA, Hussain Z, Valvano MA.
    J Clin Microbiol; 1992 Oct; 30(10):2632-7. PubMed ID: 1400963
    [Abstract] [Full Text] [Related]

  • 17. A correlation study between virulence factors and multidrug resistance among clinical isolates of Proteus mirabilis.
    Elhoshi M, El-Sherbiny E, Elsheredy A, Aboulela AG.
    Braz J Microbiol; 2023 Sep; 54(3):1387-1397. PubMed ID: 37535261
    [Abstract] [Full Text] [Related]

  • 18. [Characterization of hemolytic activity of Proteus penneri].
    Rózalski A, Bartodziejska B, Wykrota M, Serwecińska L, Lukomski S, Kotełko K.
    Med Dosw Mikrobiol; 1993 Sep; 45(1):79-83. PubMed ID: 8231450
    [Abstract] [Full Text] [Related]

  • 19. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.
    Mobley HL, Island MD, Massad G.
    Kidney Int Suppl; 1994 Nov; 47():S129-36. PubMed ID: 7869662
    [Abstract] [Full Text] [Related]

  • 20. Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains.
    Kotelko K, Kaca W, Rózalski A, Deka M.
    Acta Microbiol Pol; 1983 Nov; 32(4):345-51. PubMed ID: 6202102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.